Kadmon Oceania Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
3 result(s) found, displaying 1 to 3
-
Australian Public Assessment Report (AusPAR)New AusPAR for Rholistiq (belumosudil) for the treatment of patients with chronic graft-versus-host disease aged 12 years and older.
-
-